LabCompass

Benjamin H. Kaffenberger

Medicine · The Ohio State University

Mid career · publishing since 2009

Publications

359

Citations

5,006

Est. group size

~45

Recurring co-author estimate

Active years

18

Publishing since 2009

Research summary
AI-generated

Benjamin H. Kaffenberger's research focuses on complex and severe skin conditions, especially pyoderma gangrenosum (a rare inflammatory skin ulcer disease) and severe drug reactions like Stevens-Johnson syndrome and toxic epidermal necrolysis. His work spans clinical outcomes research, genetic risk factors (such as HLA gene variants linked to drug reactions), and hospital-based dermatology care patterns, often using large multicenter or registry datasets.

Pyoderma gangrenosumSevere cutaneous drug reactions (SJS/TEN)Inpatient and hospital dermatology careGenetic risk factors for drug hypersensitivityAutoimmune and inflammatory skin diseases

Publication output has grown substantially over the past decade, rising from about 12 papers per year in 2017 to over 40 per year by 2023-2024, with a slight decline in 2025.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 34.2/year recently
2017: 12 publications172018: 17 publications182019: 27 publications192020: 37 publications202021: 40 publications212022: 35 publications222023: 42 publications232024: 47 publications47242025: 39 publications252026: 8 publications26
Recent publications
Publishes in
  • Journal of the American Academy of Dermatology×74
  • International Journal of Dermatology×39
  • Archives of Dermatological Research×26
  • Journal of Investigative Dermatology×23
  • JAMA Dermatology×17
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile